BUT be careful: it can reduce production if too restrictive
Some reports were higher still, with 27% of employers finding GLP-1 weight loss coverage encompassed more than 15% of their annual claims in 2024, compared to 15% of employers who said the same in 2023
The 2024 average AOM semaglutide prescription rate was 23.7-fold higher than the AOM liraglutide prescription rate
While studies and assessments of GLP-1 AOMs, such as the cost-effectiveness study by the Institute for Clinical and Economic Review (ICER), 24 emphasize the potential for improved outcomes in obesity-related chronic diseases (e.g., heart disease, diabetes, osteoarthritis) and the potential related savings, the cost of AOMs must be paid up front, often exceeding the political or financial capacity of state legislatures to fund the program adequately
Try over-the-counter medication If lifestyle changes arent enough, theres still hope
Refills may not be appropriate for everyone